A team of scientists from Israel and Iceland have published research showing that an extract of spirulina algae has the potential to reduce the chances of COVID-19 patients developing a serious case of the disease.
The research, published in the peer-reviewed journal Marine Biotechnology, found that an extract of photosynthetically manipulated Spirulina is 70% effective in inhibiting the release of the cytokine TNF-a, a small signaling protein used by the immune system.
The research was conducted in a MIGAL laboratory in northern Israel with algae grown and cultivated by the Israeli company VAXA, which is located in Iceland. VAXA received funding from the European Union to explore and develop natural treatments for coronavirus.
Disney brands “The Muppet Show”, “Peter Pan” with “Offensive Content” Warning
Two Greek beaches in TripAdvisor’s best beaches in the world list (photos)
Iceland’s MATIS Research Institute also participated in the study.
In a small percentage of patients, infection with the coronavirus causes the immune system to release an excessive number of TNF-a cytokines, resulting in what is known as a cytokine storm. The storm causes acute respiratory distress syndrome and damage to other organs, the leading cause of death in COVID-19 patients.
Read more: jpost
Ask me anything
Explore related questions
